We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TCRT market cap is 29.04M. The company's latest EPS is USD -2.3520 and P/E is -0.78.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.91M | 11k | 0 | 249k | 0 |
Operating Income | -8.26M | -8.52M | -9.67M | -7.98M | -8.67M |
Net Income | -8.85M | -9.16M | -10.05M | -8.77M | -8.48M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 146k | 0 | 0 | 398k | 2.92M |
Operating Income | -53.91M | -57.86M | -80.36M | -78.75M | -35.24M |
Net Income | 137.25M | -117.8M | -79.98M | -78.75M | -37.73M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 67.34M | 64.94M | 48.64M | 27.93M | 19.44M |
Total Liabilities | 35.23M | 26.38M | 19.13M | 6.28M | 5.54M |
Total Equity | 32.11M | 38.56M | 29.51M | 21.65M | 13.9M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 95.05M | 109.11M | 146.35M | 94.87M | 64.94M |
Total Liabilities | 9.49M | 14.1M | 22.36M | 36.81M | 26.38M |
Total Equity | 85.56M | 95.01M | 123.98M | 58.06M | 38.56M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -22.1M | -29.23M | -9.38M | -16.38M | -22.76M |
Investing | -100k | -193k | -23k | -158k | -157k |
Financing | -2.11M | 6.37M | -6.16M | -18.14M | -18.14M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -49.46M | -40.85M | -57.01M | -61.47M | -29.23M |
Investing | -459k | -284k | -9.78M | -3.32M | -193k |
Financing | 40.31M | 59.15M | 102.12M | 25.78M | 6.37M |
Market Cap | 29.04M |
Price to Earnings Ratio | -0.78 |
Price to Sales Ratio | 10.05 |
Price to Cash Ratio | 0.75 |
Price to Book Ratio | 0.76 |
Dividend Yield | - |
Shares Outstanding | 16.04M |
Average Volume (1 week) | 59.62k |
Average Volume (1 Month) | 64.76k |
52 Week Change | -82.76% |
52 Week High | 10.50 |
52 Week Low | 0.66 |
Spread (Intraday) | 0.2 (10%) |
Company Name | Alaunos Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.ziopharm.com |
Industry | spec outpatient facility,nec (8093) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions